Brief: Auto Italia's Unit Enters Agreement With Chime Biologics & JHL Biotech, Among Others
Jan 29 (Reuters) - Auto Italia Holdings Ltd 0720.HK :
* UNIT & INDEPENDENT THIRD PARTY ENTER AGREEMENT WITH CHIME
BIOLOGICS, JHL BIOTECH & JHL BIOTECH (HONG KONG) AMONG OTHERS
* CONSIDERATION OF ISSUANCE US$32 MILLION; SUBSCRIPTION
PRICE FOR
EACH CBL SERIES A PREFERRED SHARE OF ABOUT US$0.617
* UPON COMPLETION, RAINBOW SURPLUS INVESTMENTS TO HOLD 51.8
MILLION CBL SERIES A PREFERRED SHARES, REPRESENTS 11.82% OF
CHIME
Source text for Eikon: urn:newsml:reuters.com:*:nHKS246sWc
Further company coverage: 0720.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Auto Italia Holdings
See all newsBrief: Auto Italia Posts HY Profit Attributable From Continuing Ops HK$138.1 Million
Brief: Auto Italia Enters Strategic Framework Agreement With B-On Global S.À R.L. And Jiangsu Changzhou EDZ
Brief: Auto Italia Sees Consolidated HY Profit Attributable Of HK$130 MLN-HK$140 MLN
Brief: Auto Italia Says Hudson Automotive Enters Sales Contract
Brief: Auto Italia To Place 50 Million Shares